rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    QGEN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Interpreting Qiagen (QGEN) International Revenue Trends
      Nov 13Yahoo FinanceQGEN
      Bank of America Reports 5.50% QIAGEN Stake

      Tipranks Press Release.

      Nov 11The Globe and MailBACQGEN
      Qiagen (QGEN) Shareholders Approve Jonathan M Pratt As CEO And Managing Director

      Qiagen (NYSE:QGEN) received shareholder approval at an Extraordinary General Meeting for Jonathan M. Pratt to become CEO and Managing Director. Jonathan M. Pratt is set to succeed Thierry Bernard in the top leadership role following the Extraordinary General Meeting vote. The board decision formalizes a transition at the top of Qiagen's management structure, shifting responsibilities from Thierry Bernard to Pratt. The leadership handover from Thierry Bernard to Jonathan M. Pratt is only one...

      Nov 11Yahoo FinanceQGEN
      Qiagen N.V. (QGEN) Shareholder/Analyst Call - Slideshow (NYSE:QGEN) 2026-11-06
      Nov 6Seeking AlphaQGEN
      Qiagen (QGEN) Stock May Be Fully Priced As Sequencing Project Expands

      Qiagen has delivered a 35.3% gain over the past three years, and recent headlines around genomics partnerships and sequencing markets keep the story in focus. The question now is whether that share price trajectory lines up with what the company’s cash flows can reasonably support. With a 35.3% return over three years, Qiagen now asks investors to judge whether that run is backed by the cash its business can generate over time. New projects in areas such as precision medicine, clinical...

      Nov 6Yahoo FinanceQGEN
      Qiagen shareholders approve Jonathan Pratt as managing director
      Nov 6Investing.comQGEN
      QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director
      Nov 6Yahoo FinanceQGEN
      Compared to Estimates, Qiagen (QGEN) Q3 Earnings: A Look at Key Metrics
      Nov 5Yahoo FinanceQGEN
      Qiagen (QGEN) Surpasses Q3 Earnings and Revenue Estimates
      Nov 4Yahoo FinanceQGEN
      Qiagen: Q3 Earnings Snapshot
      Nov 4Yahoo FinanceQGEN
      Qiagen earnings in focus as $10.8 billion EQT deal looms
      Nov 4Investing.comQGEN
      Do Options Traders Know Something About Qiagen Stock We Don't?
      Oct 31Yahoo FinanceQGEN
      Qiagen (QGEN) On Its €9.7b Takeover Deal Still Looks Fully Valued
      Oct 31Yahoo FinanceQGEN
      Qiagen (QGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
      Oct 28Yahoo FinanceQGEN
      Barclays Downgrades QIAGEN to Equalweight From Overweight, Price Target is $53
      Oct 28Yahoo FinanceQGEN
      EQT’s Qiagen Deal Ends Years Of Takeover Speculation – Merger Arbitrage Mondays (NYSE:QGEN)
      Oct 26Seeking AlphaQGEN
      QIAGEN Agrees to €46.50-Per-Share Takeover by Crown NL Bidco

      Detailed price information for Qiagen N.V. (QGEN-N) from The Globe and Mail including charting and trades.

      Oct 24The Globe and MailQGEN
      DZ BANK AG downgrades Qiagen (QGEN) to a Hold

      Detailed price information for Qiagen N.V. (QGEN-N) from The Globe and Mail including charting and trades.

      Oct 23The Globe and MailQGEN
      Qiagen agrees to private equity takeover
      Oct 23Yahoo FinanceQGEN
      Qiagen: Unanimous Acceptance Takeover Nears Close (Rating Downgrade)
      Oct 23Seeking AlphaQGEN
      Baird Downgrades QIAGEN to Neutral From Outperform, $52 Price Target
      Oct 23Yahoo FinanceQGEN
      Qiagen (QGEN) was downgraded to a Hold Rating at J.P. Morgan

      Detailed price information for Qiagen N.V. (QGEN-N) from The Globe and Mail including charting and trades.

      Oct 23The Globe and MailQGEN
      Long-Awaited Qiagen Buyout Closes At 15x EBITDA Multiple as Slow Growth Curbs Pricing
      Oct 22BenzingaQGEN
      This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
      Oct 22BenzingaQGEN
      Berenberg Raises Price Target on QIAGEN to $52.22 From $45.50, Keeps Hold Rating
      Oct 22Yahoo FinanceQGEN
      Breakingviews - COMMENTARY: Lab testing LBO offers murky result for both sides
      Oct 22ReutersQGEN
      Qiagen to Be Acquired by EQT for $12.1 Billion in All-Cash Deal

      Qiagen (QGEN) said Wednesday it agreed to be acquired by EQT Private Equity for 46.50 euros ($52.26)

      Oct 22Yahoo FinanceQGEN
      JPMorgan downgrades Qiagen stock rating on EQT buyout deal
      Oct 22Investing.comQGEN
      Swedish investor EQT launches €10.8 billion bid for Germany's Qiagen
      Oct 22Yahoo FinanceQGEN
      EQT to buy molecular testing firm Qiagen for $10.8 billion
      Oct 21ReutersQGENTMO
      QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer
      Oct 21Yahoo FinanceQGEN
      EQT to acquire QIAGEN for €10.8 billion in cash deal
      Oct 21Investing.comQGEN
      Buyout firm EQT acquires German diagnostics group in €10.8bn deal
      Oct 21Financial TimesQGEN
      QIAGEN reports Q3 sales of $548M, adjusted EPS of $0.65
      Oct 21Investing.comQGEN
      Qiagen Preliminary Q3 Adjusted EPS, Sales Beat Estimates
      Oct 21Yahoo FinanceQGEN
      QIAGEN reports preliminary Q3 2026 results
      Oct 21Yahoo FinanceQGEN
      Bank of America Builds 5.73% Stake in Qiagen via Shares and Derivatives

      Detailed price information for Qiagen N.V. (QGEN-N) from The Globe and Mail including charting and trades.

      Oct 21The Globe and MailQGEN
      EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen
      Oct 21BloombergQGEN
      Qiagen (QGEN) Stock Looks Like A Bargain On Cash Flow
      Oct 20Yahoo FinanceQGEN
      EQT in advanced talks to buy testing firm Qiagen, Bloomberg News reports
      Oct 20ReutersKKRQGEN
      Update: Market Chatter: Qiagen Receives Binding Acquisition Offer of Over $50 Per Share From EQT AB
      Oct 20Yahoo FinanceQGEN
      Qiagen shares surge on report of advanced EQT takeover talks
      Oct 20Yahoo FinanceKKRQGEN
      Market Chatter: Qiagen Receives Binding Acquisition Offer of Over $50 Per Share From EQT AB
      Oct 20Yahoo FinanceQGEN
      Qiagen jumps on report EQT in advanced talks to purchase the testing firm (QGEN:NYSE)
      Oct 20Seeking AlphaQGEN
      EQT Is in Advanced Talks to Buy Testing Firm Qiagen
      Oct 20BloombergQGEN
      QIAGEN hosts global TB summit as funding cuts threaten programs
      Oct 13Investing.comQGEN
      BlackRock Reports Significant 11.66% Stake and 13.04% Voting Rights in Qiagen

      Detailed price information for Qiagen N.V. (QGEN-N) from The Globe and Mail including charting and trades.

      Oct 7The Globe and MailQGEN
      Barclays Upgrades QIAGEN to Overweight From Equalweight
      Oct 6Yahoo FinanceQGEN
      QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery
      Oct 6Yahoo FinanceQGEN
      Qiagen gains on report talks with potential buyer have advanced (QGEN:NYSE)

      Qiagen (QGEN) shares jump on takeover talk as PE firms and a US molecular testing buyer eye a deal at a “realistic premium.” Get the latest update.

      Oct 2Seeking AlphaQGEN

      This is the newest page. Registered accounts read further back.